US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 54.110
  • +2.250+4.34%
Trading Nov 22 15:07 ET
3.41BMarket Cap-42606P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MoonLake Immunotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

MoonLake Immunotherapeutics Earnings Reports

  • MoonLake Immunotherapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:08 ET

  • MoonLake Immunotherapeutics | 8-K: MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

    Nov 7 07:08 ET

  • MoonLake Immunotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 08:06 ET

  • MoonLake Immunotherapeutics | 8-K: MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11

    Aug 7 08:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 5, 2024

    Strong Buy

    • Buy

      81.82%

    • Hold

      18.18%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data